Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Superoxide anion radical (O₂•⁻) is a small, highly reactive oxygen species classified as a free radical and forms through the one-electron reduction of molecular oxygen, primarily during mitochondrial respiration, enzymatic cascades, and oxidative bursts in immune cells. It is not a protein or macromolecular drug target, but rather a transient chemical species central to redox biology and implicated in both normal cellular signaling and numerous pathological states. Though it acts as a signaling molecule at low concentrations, elevated superoxide contributes to tissue injury in many diseases via oxidative modification of biomolecules. Cellular defense mechanisms such as superoxide dismutases (SODs) rapidly convert O₂•⁻ into less reactive species, underscoring its hazardous potential and lack of suitability as a direct therapeutic target. Therefore, "superoxide radical" is not considered a canonical drug target (such as a receptor or enzyme), but rather a key reactive molecule with broad biological and pathological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superoxide anion radical (O₂•⁻).